Medicare Enrolled
Dr. Harris Naina, MD
Hematology & Oncology · Fort Worth, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Naina from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Naina?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Naina
Dr. Harris Naina is a hematology & oncology specialist in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Naina performed 24,055 Medicare services across 2,000 unique beneficiaries.
Between the years covered by Open Payments, Dr. Naina received a total of $99,599 from 38 pharmaceutical and/or device companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Naina is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 32% volume in TX
$99,599 industry payments
Medicare Practice Summary
Medicare Utilization ↗24,055
Medicare services
Top 32% in TX for hematology & oncology
2,000
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,266 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
4,900 | $0 | $2 |
| Azacitidine chemotherapy injection An injection of the medication azacitidine, measured at 1 mg per unit. |
4,500 | $0 | $13 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
3,600 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 3,600 | $43 | $137 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
1,078 | $19 | $180 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
720 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
689 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
597 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
478 | $10 | $64 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
460 | $92 | $368 |
| Injection, granisetron hydrochloride, 100 mcg | 370 | $0 | $24 |
| Anti-nausea injection (Aloxi/palonosetron) | 340 | $1 | $114 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
273 | $93 | $357 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
244 | $136 | $496 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
163 | $9 | $56 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
124 | $103 | $707 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
124 | $6 | $431 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
121 | $6 | $31 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
116 | $17 | $60 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
113 | $35 | $143 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
107 | $12 | $108 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
104 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
104 | $6 | $34 |
| Iron level test | 100 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
100 | $9 | $35 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
97 | $13 | $60 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
79 | $56 | $211 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
68 | $49 | $313 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
59 | $22 | $157 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
55 | $132 | $694 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
47 | $59 | $298 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
43 | $11 | $96 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
42 | $51 | $344 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
41 | $16 | $100 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
39 | $15 | $76 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 37 | $88 | $657 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
36 | $22 | $161 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
36 | $1 | $7 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 36 | $132 | $3,675 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
26 | $1,118 | $4,802 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
26 | $25 | $145 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
25 | $4 | $25 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
25 | $2 | $19 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
23 | $1 | $8 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $10 | $75 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
22 | $62 | $247 |
| New patient office visit, complex (60-74 min) | 20 | $172 | $709 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $108 | $565 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
11 | $1,163 | $4,929 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
77.0% medium
21.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$99,599
Total received (2018-2024)
Avg $14,228/year across 7 years
Top 7% in TX for hematology & oncology
38
Companies
143
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$67,910 (68.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$30,127 (30.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,562 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,927
2023
$30,711
2022
$9,116
2021
$17,995
2020
$13,508
2019
$2,221
2018
$121
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BeiGene USA, Inc.
$45,215
Ipsen Biopharmaceuticals, Inc
$19,740
Celgene Corporation
$11,491
Janssen Scientific Affairs, LLC
$6,808
E.R. Squibb & Sons, L.L.C.
$3,108
Gilead Sciences, Inc.
$2,752
Seattle Genetics, Inc.
$1,681
Takeda Pharmaceuticals U.S.A., Inc.
$1,650
Janssen Biotech, Inc.
$1,638
Seagen Inc.
$1,415
GENZYME CORPORATION
$1,279
Epizyme, Inc.,
$1,250
BeiGene, Ltd.
$525
ABBVIE INC.
$125
Shionogi Inc
$124
Novartis Pharmaceuticals Corporation
$99
Tempus AI, Inc
$59
Amgen Inc.
$56
Alexion Pharmaceuticals, Inc.
$48
Kite Pharma, Inc.
$48
Karyopharm Therapeutics Inc.
$47
PFIZER INC.
$47
Adaptive Biotechnologies Corporation
$47
Genentech USA, Inc.
$38
Novocure Inc.
$37
Astellas Pharma US Inc
$34
Daiichi Sankyo Inc.
$31
Rigel Pharmaceuticals, Inc.
$30
ADC Therapeutics America, Inc.
$28
AbbVie, Inc.
$24
Verastem, Inc.
$19
Genmab U.S., Inc.
$18
GlaxoSmithKline, LLC.
$17
Iovance Biotherapeutics, Inc.
$17
Incyte Corporation
$14
Bio Products Laboratory USA, Inc.
$14
Dova Pharmaceuticals
$13
Acrotech Biopharma LLC
$12
Top 3 companies account for 76.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · Amtagvi · BELEODAQ · BOSULIF · BRUKINSA · CABLIVI · Copiktra · Cresemba · DARZALEX · Doptelet · ELITEK · ELREXFIO · ENJAYMO · EPKINLY · Epkinly · GAZYVA · Gammaplex · IMBRUVICA · INREBIC · JEVTANA · KANJINTI · Kyprolis · MEKINIST · MONJUVI · Mulpleta · OJJAARA · OPDIVO · Oncology · PROSTATE CANCER - DISEASE · REBLOZYL · Revlimid · SARCLISA · SCEMBLIX · TALZENNA · TAZVERIK · TECVAYLI · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tazverik · ULTOMIRIS · VELCADE · VENCLEXTA · Vanflyta · Venclexta · XPOVIO · Yescarta · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for hematology & oncology in TX.
Equivalent to $414 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
47
Per 100K population
2.2
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Naina is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 7% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Naina experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Naina performed 4,900 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Naina receive payments from pharmaceutical companies?
Yes. Dr. Naina received a total of $99,599 from 38 companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Naina's costs compare to other hematology & oncology specialists in Fort Worth?
Dr. Naina's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Naina) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Fort Worth
Browse hematology & oncology specialists in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology